EIF4EBP1 and neoplasm: Accordingly, analysis of RNA sequencing data from 1100 breast cancer patients in the TCGA demonstrated that high levels of 4E-BP1 in the primary tumor predict poor survival in the first 5 years post-diagnosis (Fig. 4l).